HC Surgical Specialists Ltd (SG:1B1)
SGX:1B1
Want to see SG:1B1 full AI Analyst Report?
1B1 Stock Chart & Stats
S$0.36
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.36
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.29 - S$0.40
Previous CloseN/A
Volume0.00
Average Volume (3M)50.29K
Market Cap
S$59.98M
Enterprise ValueS$56.74M
Total Cash (Recent Filing)S$5.73M
Total Debt (Recent Filing)S$2.78M
Price to Earnings (P/E)4.3
Beta0.08
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.37%
Share Statistics
EPS (TTM)0.06
Shares Outstanding156,309,900
10 Day Avg. Volume16,820
30 Day Avg. Volume50,290
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.09
Price to Sales (P/S)2.29
P/FCF Ratio6.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High Profitability And MarginsSustained very high gross and unusually strong operating/net margins indicate durable underlying unit economics and pricing power in clinical services. High margins provide a cushion versus revenue dips, support cash generation and margin resilience over the next several months.
Improved Capital StructureMarked reduction in leverage meaningfully lowers financial risk and interest burden, increasing balance-sheet flexibility. This supports investment, steady operations and the ability to withstand shocks or fund strategic initiatives without immediate refinancing pressure.
Strong Cash ConversionClose tracking of free cash flow to net income and consistent positive operating cash flow reflect high cash conversion from clinical operations. That reliability supports working capital, dividends or reinvestment and reduces dependence on external financing.
Bears Say
Sharp Revenue DeclinePersistently weak and sharply negative revenue growth undermines the sustainability of current profit levels. If patient volumes or service demand remain suppressed, high margins may compress and limit long-term earnings durability and growth potential.
Negative Free-cash-flow Growth TrendDespite good cash conversion this year, repeatedly negative free-cash-flow growth reduces capacity to expand clinics, invest in equipment, or build reserves. Ongoing negative FCF momentum can constrain strategic flexibility and dividend sustainability over months ahead.
ROE And Earnings VolatilityLarge swings in ROE and earnings indicate inconsistent profitability drivers, suggesting dependence on episodic items or variable volumes. This volatility makes future earnings and dividend predictability weaker and raises execution risk for sustained returns.
HC Surgical Specialists Ltd News
1B1 FAQ
What was HC Surgical Specialists Ltd’s price range in the past 12 months?
HC Surgical Specialists Ltd lowest share price was S$0.28 and its highest was S$0.40 in the past 12 months.
What is HC Surgical Specialists Ltd’s market cap?
HC Surgical Specialists Ltd’s market cap is S$59.98M.
When is HC Surgical Specialists Ltd’s upcoming earnings report date?
HC Surgical Specialists Ltd’s upcoming earnings report date is Jul 23, 2026 which is in 63 days.
How were HC Surgical Specialists Ltd’s earnings last quarter?
HC Surgical Specialists Ltd released its earnings results on Jan 13, 2026. The company reported S$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.026.
Is HC Surgical Specialists Ltd overvalued?
According to Wall Street analysts HC Surgical Specialists Ltd’s price is currently Overvalued.
Does HC Surgical Specialists Ltd pay dividends?
HC Surgical Specialists Ltd pays a Notavailable dividend of S$0.012 which represents an annual dividend yield of 3.37%. See more information on HC Surgical Specialists Ltd dividends here
What is HC Surgical Specialists Ltd’s EPS estimate?
HC Surgical Specialists Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HC Surgical Specialists Ltd have?
HC Surgical Specialists Ltd has 156,309,900 shares outstanding.
What happened to HC Surgical Specialists Ltd’s price movement after its last earnings report?
HC Surgical Specialists Ltd reported an EPS of S$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.571%.
Which hedge fund is a major shareholder of HC Surgical Specialists Ltd?
Currently, no hedge funds are holding shares in SG:1B1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HC Surgical Specialists Ltd
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Technical Analysis
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
UG Healthcare Corp. Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―